NASDAQ · Drug Manufacturers - Specialty & Generic

Lantheus Holdings, Inc. (LNTH) Stock

$100.12 -0.06% NASDAQ: LNTH Healthcare

Valuation

MetricValue
Price$100.12
Market Cap$6.52B
P/E Ratio23.74
P/B Ratio4.97
P/S Ratio4.18
EPS (TTM)$3.41
52-Week High$111.86
52-Week Low$49.67
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE23.27%
ROA11.40%
ROCE14.54%
Gross Margin20.17%
Operating Margin20.17%
Net Margin17.69%
Debt/Equity0.48
Current Ratio2.70

Annual Financials (USD)

Metric20212022202320242025
Revenue$425.0M$935.0M$1.3B$1.5B$1.5B
Operating Profit$-61.0M$36.0M$365.0M$457.0M$311.0M
Net Profit$-71.0M$28.0M$327.0M$312.0M$234.0M
EPS$-1.06$0.40$4.65$4.36$3.41
Op Margin-14.3%3.9%28.1%29.8%20.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$864.0M$1.3B$1.7B$2.0B$2.2B
Total Liabilities$399.0M$874.0M$835.0M$892.0M$1.1B
Cash$99.0M$416.0M$714.0M$913.0M$359.0M
Borrowings$191.0M$584.0M$617.0M$619.0M$619.0M

Latest News

RadioMedix Appoints Brian A. Markison to Board of Directors GlobeNewswire · Jul 15, 2026 LNTH: Lowering target price to $107.00 Argus Research · Jul 15, 2026 3 Reasons to Avoid LNTH and 1 Stock to Buy Instead StockStory · Jul 14, 2026 1 Small-Cap Stock with Competitive Advantages and 2 We Brush Off StockStory · Jul 13, 2026 B. Riley Adjusts Price Target on Lantheus Holdings to $129 From $97, Maintains Buy Rating MT Newswires · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$54.0M$282.0M$305.0M$545.0M$390.0M
Investing Cash Flow$-8.0M$-295.0M$-41.0M$-278.0M$-663.0M
Financing Cash Flow$3.0M$-72.0M$-14.0M$-122.0M$-326.0M
Net Cash Flow$18.0M$317.0M$298.0M$199.0M$-554.0M
Free Cash Flow$42.0M$263.0M$259.0M$493.0M$354.0M

Valuation & Return Ratios

MetricValue
PEG Ratio3.33
EV / EBITDA14.05
FCF Yield5.96%
Quick Ratio2.89
Interest Coverage15.26
Return 1Y82.86%
Return 3Y51.66%
Return 5Y287.90%

Ownership

Insiders Held2.09%
Institutions Held116.40%
Institutions Float Held118.88%
Institutional HolderSharesReport Date
Blackrock Inc.8,183,1932026-03-31
Farallon Capital Management LLC5,583,4792026-03-31
Janus Henderson Group PLC4,774,8412026-03-31
FMR, LLC4,626,4532026-03-31
Vanguard Portfolio Management LLC3,174,2742026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $340.42 +1.11% 38.93 $5.00T 0.32%
MSFTMicrosoft Corporation $522.61 -1.35% 28.68 $3.88T 0.76%
GOOGLAlphabet Inc. $348.29 -0.63% 16.94 $4.22T 0.26%
AMZNAmazon.com, Inc. $254.06 -2.25% 19.82 $2.73T 0.00%
METAMeta Platforms, Inc. $720.89 -0.06% 27.93 $1.84T 0.28%

About Lantheus Holdings, Inc.

Lantheus Holdings, Inc. is led by CEO Mary Anne Heino, employs 1,193 people, headquartered in Bedford, US, publicly traded since 2015.

Lantheus Holdings, Inc. (LNTH) stock trades at $100.12 with a market capitalization of $6.52B. The stock is valued at a price-to-earnings (P/E) ratio of 23.74, price-to-book of 4.97, price-to-sales of 4.18. Over the past 52 weeks the stock has ranged between $49.67 and $111.86, and currently trades 10.5% below its 52-week high.

On profitability, Lantheus Holdings, Inc. generates a return on equity (ROE) of 23.27% — well above the market average, a sign of a high-quality business, return on capital employed of 14.54%, an operating margin of 20.17%, a net profit margin of 17.69%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides